Oncolytics Biotech (ONCY) Receiving Somewhat Favorable Press Coverage, Accern Reports


Headlines about Oncolytics Biotech have been trending somewhat positive this week, according to Accern Sentiment. The research group rates the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time.



from Biotech News